With so many firms locked in fierce competition, even a long-established maker like Yung Shin Pharmaceutical, founded in 1965 and the largest pharmaceuticals firm in Taiwan, relied on generic drugs for NT $ 2.7 billion, or 90 %, of its revenues in 2008, and its share of the domestic drug market is only a modest 6.5 %.
僧多粥少、競爭白熱化之下，即便是最老牌（成立於 1965 年）、國內規模最大的製藥公司「永信藥品」，2008 年的學名藥收入台幣 27 億元，占該公司總營業額的 9 成，但也僅是國內藥品市場的 6.5％而已。